CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII INFECTION

Clinical trials for CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII INFECTION explained in plain language.

Never miss a new study

Get alerted when new CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII INFECTION trials appear

Sign up with your email to follow new studies for CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug combo tested against superbug infections in hospital patients

Knowledge-focused Recruiting now

This study looks at how well a drug combination called sulbactam-durlobactam works against hard-to-treat infections caused by a superbug called CRAB. About 200 hospitalized adults will be observed, and their outcomes will be compared to those receiving other treatments. The goal …

Matched conditions: CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII INFECTION

Sponsor: Sichuan Provincial People's Hospital • Aim: Knowledge-focused

Last updated May 26, 2026 05:49 UTC

CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII INFECTION

Get alerted when new CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII INFECTION trials appear

New drug combo tested against superbug infections in hospital patients